John L Marshall is an internationally recognized expert in new drug development for GI cancer, with expertise in phase I, II, and III trial design, and has served as Principal Investigator for more than one hundred clinical trials throughout his career. While he has an interest in many areas of cancer research, his primary focus is on the use of precision medicine in treating cancer. In 2009, he established the Otto J Ruesch Center for the Cure of GI Cancers. In 2015, Dr. Marshall both established and directed the Precision Oncology Alliance. He currently is serving as the Oncology CMO for Indivumed, creating a global precision medicine research network. Dr. Marshall received his training at Duke University, the University of Louisville, and Georgetown University.

• 

  Advisor in DoMore

  Personalized medicine made simple with artificial intelligence